In conclusion, we found NK1.1/CD161+ cells in a substantial fraction of TCR-Vβ-specific overrepresented T cells in CLL and can show that loss of CD1d in the mouse model significantly accelerates disease development. This evidence concerns the gene CD1D and B-cell chronic lymphocytic leukemia.